Currently we test and support the following browsers:
Two little girls find ways to help during their brother's cancer treatment.
Yeshaai Govender's family traveled nearly 9,000 miles to find the best brain tumor treatment for their son.
Researchers from St. Jude Children’s Research Hospital and the Pediatric Brain Tumor Consortium (PBTC) presented today at the American Society of Clinical Oncology the findings of a pediatric brain tumor study using an experimental drug that targets the underlying genetic makeup of the tumor.
Where would two physicians turn if their son had a brain tumor? One couple found world-class treatment—as well as their son’s trademark smile—at St. Jude.
A team of investigators led by St. Jude has announced that improvements in the treatment of the childhood brain cancer medulloblastoma have significantly increased the rate of survival of children with this disease.
A team of investigators led by St. Jude Children's Research Hospital has announced that improvements in the treatment of the childhood brain cancer medulloblastoma have significantly increased the rate of survival of children with this disease.
Thanks to the St. Jude Neurobiology and Brain Tumor Program, victory is within reach for kids with medulloblastoma.
Irradiation therapy for the brain cancer medulloblastoma is more likely to impair IQ and reading skills of younger children than older children even if the dose of radiation is reduced.
Some children with a rare brain tumor that is considered almost universally fatal can be saved if they receive radiation therapy followed by tandem (given one after the other) cycles of high-dose chemotherapy.
Irradiation and high-dose chemotherapy used to treat two types of brain tumors can cause changes in the brain's white matter that look like tumors when seen on MRI scans.
Clinical researchers are getting closer to an international clinical trial to improve guidelines for treatment of medulloblastoma.